CYTX

Cytori Strengthens European Union Sales, Training and Service Operations - 11/25 - 07:00 AM ET

Seven Investigator-Initiated Clinical Studies Announced - 11/19 - 07:00 AM ET

Cytori Therapeutics' Big Upside - 11/12 - 07:10 AM ET

BRIEF-Cytori Therapeutics Q3 results - 11/10 - 07:14 AM ET

Composition of Matter Patent Allowance Covers Adipose-Derived Stem and Progenitor Cells - 10/08 - 07:30 AM ET

Cytori Thera Warrants Excitement - 09/25 - 07:10 AM ET

Surgeons Report Clinical Experience Using Cytori's Celution(R) 800/CRS System with 52 Patients - 09/24 - 08:43 AM ET

Cytori Therapeutics Challenges Resistance On Volume Spike - 08/28 - 10:44 AM ET

Cytori Therapeutics Climbs In Pre-Market - 08/19 - 08:57 AM ET

Cytori signs LOI with Astrea International - 08/05 - 12:31 PM ET

Cytori receives notice of allowance from US Patent Office - 07/17 - 08:41 AM ET

Cytori Therapeutics gets patent allowance for graft used in surgeries - 07/16 - 07:18 AM ET

Cytori announces sale of first European Union StemSource Bank - 07/15 - 01:29 PM ET

Cytori sells StemSource Cell Bank to Biohellenika - 07/15 - 09:33 AM ET

Cytori Sells First European Union StemSource(R) Bank; Industry Leading Biohellenika of Greece Acquires Exclusive Rights - 07/14 - 10:51 AM ET

Cytori Therapeutics (CYTX) - 06/25 - 07:10 AM ET

CYTX: Issued U.S. Patent re Celution(R) System Technology - 06/24 - 08:59 AM ET

U.S. Patent on Cytori's Celution(R) System Technology Issued; Celution(R) System Commercialization not Impacted by Recent 6,777,231 Patent Inventorship Decision - 06/24 - 08:25 AM ET

Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent - 06/19 - 08:08 PM ET

Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent - 06/19 - 03:48 PM ET

Page 1 of 3     1  2   3      Previous  |  Next

<< Back to Stock Index